These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25155589)

  • 1. In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model.
    Garrido V; Collantes M; Barberán M; Peñuelas I; Arbizu J; Amorena B; Grilló MJ
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6660-7. PubMed ID: 25155589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.
    Kadurugamuwa JL; Sin LV; Yu J; Francis KP; Kimura R; Purchio T; Contag PR
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3130-7. PubMed ID: 14506020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of antibiotic treatment of implant-associated
    Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
    Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do fluorescence spectroscopy and multimodal fluorescence imaging help to dissect the enhanced efficiency of the vancomycin-rifampin combination against Staphylococcus aureus infections?
    Boudjemaa R; Briandet R; Fontaine-Aupart MP; Steenkeste K
    Photochem Photobiol Sci; 2017 Sep; 16(9):1391-1399. PubMed ID: 28664201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model.
    Yu J; Wu J; Francis KP; Purchio TF; Kadurugamuwa JL
    J Antimicrob Chemother; 2005 Apr; 55(4):528-34. PubMed ID: 15743898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
    Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.
    Ueng SW; Lin SS; Wang IC; Yang CY; Cheng RC; Liu SJ; Chan EC; Lai CF; Yuan LJ; Chan SC
    J Orthop Surg Res; 2016 Apr; 11(1):52. PubMed ID: 27121956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.
    Bauer J; Siala W; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2726-37. PubMed ID: 23571532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.
    Pascual A; Ramirez de Arellano E; Perea EJ
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):515-7. PubMed ID: 7957277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in
    Richter K; Thomas N; Zhang G; Prestidge CA; Coenye T; Wormald PJ; Vreugde S
    Front Cell Infect Microbiol; 2017; 7():280. PubMed ID: 28690982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
    Salem AH; Elkhatib WF; Noreddin AM
    J Pharm Pharmacol; 2011 Jan; 63(1):73-9. PubMed ID: 21155818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa.
    Su S; Yin P; Li J; Chen G; Wang Y; Qu D; Li Z; Xue X; Luo X; Li M
    J Infect Public Health; 2020 May; 13(5):791-799. PubMed ID: 31813834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of silk fibroin-nano silver against
    Jia M; Chen Z; Guo Y; Chen X; Zhao X
    Int J Nanomedicine; 2017; 12():2933-2939. PubMed ID: 28435269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
    Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
    Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
    Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
    Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of
    Vila T; Kong EF; Montelongo-Jauregui D; Van Dijck P; Shetty AC; McCracken C; Bruno VM; Jabra-Rizk MA
    Virulence; 2021 Dec; 12(1):835-851. PubMed ID: 33682623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.